Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Guangdong Marubi Biotechnology CoSHSE:603983 +6.11%86 Return-on-Tangible-Asset is 5.10% as of Jun. 2026, which is 52% below its 10-year median of 10.67. GuruFocus rates SHSE:603983 with a GF Score™ of 86/100 and a GF Value™ of ¥42.77 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 2,002 Consumer Packaged Goods companies, Guangdong Marubi Biotechnology Co ranks better than 60.99% on this metric.
The historical rank and industry rank for Guangdong Marubi Biotechnology Co's Return-on-Tangible-Asset or its related term are showing as below:
SHSE:603983'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 5.44 Med: 10.67 Max: 22.6
Current: 5.44
During the past 13 years, Guangdong Marubi Biotechnology Co's highest Return-on-Tangible-Asset was 22.60%. The lowest was 5.44%. And the median was 10.67%.
SHSE:603983's Return-on-Tangible-Asset is ranked better than 60.99% of 2002
companies
in the Consumer Packaged Goods industry
Industry Median: 3.52
vs SHSE:603983: 5.44
Guangdong Marubi Biotechnology Co (SHSE:603983) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Guangdong Marubi Biotechnology Co Return-on-Tangible-Asset Related Terms
Guangdong Marubi Biotechnology Co Return-on-Tangible-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guangdong Marubi Biotechnology Co Return-on-Tangible-Asset Chart
SHSE:603983 vs PG, CL, EL: Return-on-Tangible-Asset Comparison
For the Household & Personal Products subindustry, Guangdong Marubi Biotechnology Co's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Guangdong Marubi Biotechnology Co Return-on-Tangible-Asset vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Guangdong Marubi Biotechnology Co's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Guangdong Marubi Biotechnology Co's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Jun. 2026) net income data.
What does a Return-on-Tangible-Asset of 5.10% mean?
Guangdong Marubi Biotechnology Co (SHSE:603983) has a Return-on-Tangible-Asset of 5.10% as of Jun. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Guangdong Marubi Biotechnology Co and its competitors. This is 52% below median its historical median of 10.67. Over the past decade, Guangdong Marubi Biotechnology Co's Return-on-Tangible-Asset has ranged from 5.44 to 22.60. According to the industry distribution chart, Guangdong Marubi Biotechnology Co ranks #781 out of 2002 companies in the Consumer Packaged Goods industry, placing it in the top 39%.
Is Guangdong Marubi Biotechnology Co's Return-on-Tangible-Asset too high?
Guangdong Marubi Biotechnology Co's current Return-on-Tangible-Asset of 5.10% is 52% below median its 10-year median of 10.67. Over the past 10 years, this metric has ranged from a low of 5.44 to a high of 22.60. The Consumer Packaged Goods industry median Return-on-Tangible-Asset is 3.52. Guangdong Marubi Biotechnology Co's value of 5.10% is 44.9% above this industry median. Based on the distribution chart, Guangdong Marubi Biotechnology Co ranks #781 out of 2002 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, Guangdong Marubi Biotechnology Co has a GF Score™ of 86/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Guangdong Marubi Biotechnology Co's Return-on-Tangible-Asset compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Guangdong Marubi Biotechnology Co ranks #781 out of 2002 companies for Return-on-Tangible-Asset. This puts Guangdong Marubi Biotechnology Co in the upper half of its industry. The industry median Return-on-Tangible-Asset is 3.52. Guangdong Marubi Biotechnology Co's value of 5.10% is 44.9% above this benchmark. Historically, Guangdong Marubi Biotechnology Co's own Return-on-Tangible-Asset has ranged from 5.44 to 22.60 over the past decade. While the company's 10-year median is 10.67 vs. the industry median of 3.52, Guangdong Marubi Biotechnology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Consumer Packaged Goods company?
The median Return-on-Tangible-Asset among Consumer Packaged Goods companies is 3.52, based on 2,002 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Guangdong Marubi Biotechnology Co's current Return-on-Tangible-Asset of 5.10% is 44.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Guangdong Marubi Biotechnology Co and its competitors. For the Consumer Packaged Goods industry, the median Return-on-Tangible-Asset is 3.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Guangdong Marubi Biotechnology Co's current Return-on-Tangible-Asset is 5.10%, which is 52% below median its own 10-year median of 10.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guangdong Marubi Biotechnology Co stock overvalued right now?
Based on GuruFocus' analysis, Guangdong Marubi Biotechnology Co (SHSE:603983) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥42.77, compared to a current price of ¥32.81 — trading 23.3% below its estimated fair value. The current Return-on-Tangible-Asset is 5.10%, which is 52% below median its 10-year median of 10.67 and 44.9% above the Consumer Packaged Goods industry median of 3.52. Guangdong Marubi Biotechnology Co's overall GF Score™ is 86/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Guangdong Marubi Biotechnology Co (SHSE:603983), the current Return-on-Tangible-Asset is 5.10% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Guangdong Marubi Biotechnology Co (SHSE:603983) Overvalued in 2026?
Based on GuruFocus' analysis, Guangdong Marubi Biotechnology Co stock appears to be undervalued.
The current stock price of ¥32.81 is trading 23.3% below its estimated GF Value™ of ¥42.77.
GuruFocus considers Guangdong Marubi Biotechnology Co to be Modestly Undervalued.
Key valuation signals for SHSE:603983:
Return-on-Tangible-Asset: 5.10% (52% below median its 10-year median of 10.67)
GF Value™: ¥42.77 vs. price of ¥32.81 (23.3% below fair value)
Industry Position: 44.9% above the Consumer Packaged Goods median (#781 of 2002)
No single metric tells the full story. See the SHSE:603983 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603983 has been successfully added to your 
